Vericel's valuation has moderated after a 20% share price drop, prompting a shift from sell to neutral. MACI remains the company's primary growth engine, with strong sales momentum and successful surgeon training on new indications. The stock enjoys bullish analyst firm support and Vericel's balance sheet is in a strong position.

CNBC's Arjun Kharpal reports on key takeaways from his brief interview with Nvidia CEO Jensen Huang at the VivaTech conference in Paris.

Archer Aviation is a high-risk, high-reward play, driven by a massive eVTOL market opportunity and strong investor optimism despite being pre-revenue. The company's solid liquidity, operational milestones, and $6 billion order backlog provide a decent runway and future growth potential, though profitability remains distant. The underappreciated defense partnership with Anduril offers near-term revenue potential and offsets commercial delays, enhancing Archer's long-term prospects.

Dividend investing is a proven successful stretgy for creating wealth, but there are significant risks associated with chasing high-yields.

Meta Platforms (META) on Thursday announced a lawsuit against a Hong Kong-based company that has managed to work around the social media giant's advertising detection technology to promote AI-powered explicit apps.

Through the first four months of this year, the White House's often-harsh treatment of U.S. trading partners was a headwind for equity investors. For now, it appears to be on the back burner.

BOISE, Idaho , June 12, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or the "Company") announced today that as a result of excess demand, it has agreed with the syndicate of underwriters led by National Bank of Canada Financial Markets and BMO Capital Markets, on behalf of themselves and a syndicate of underwriters (the "Underwriters") to increase the size of its previously announced bought deal financing. Perpetua Resources will now issue 24,622,000 common shares, no par value, of the Company (the "Common Shares") at a price of US$13.20 per Common Share (the "Offering Price") for …

Software firm Datadog Inc (NASDAQ:DDOG) is trading 2.8% higher at $121.90, enjoying a lift after being maintained at a "buy" rating at Needham.

Flotek Industries (FTK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Bristol Myers' Sotyktu hits key goals in late-stage PsA trial, fueling hopes for expansion amid recent pipeline setbacks.

Explore Broadcom Inc.'s (AVGO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Amicus Therapeutics is a commercial-stage biotech with a focused pipeline in Fabry, Pompe, and rare kidney diseases. Galafold, its lead therapy, is the only approved oral treatment for Fabry disease and is driving consistent revenue growth. Key growth drivers for Galafold include expanding patient reach, new markets, increased market share, and high patient adherence.

An Air India Boeing Dreamliner plane with 242 passengers and crew aboard crashed shortly after takeoff from Ahmedabad in western India, local officials and the carrier said Thursday. The aircraft was bound for London Gatwick Airport.

SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon and certain of Organon's executives with violations of the Securities Exchange Act of 1934.

Tuniu Corporation (NASDAQ:TOUR ) Q1 2025 Earnings Conference Call June 12, 2025 8:00 AM ET Company Participants Anqiang Chen - Corporate Participant Financial Controller - Corporate Participant Dunde Yu - Founder, Chairman & CEO Mary Chen - Investor Relations Director Conference Call Participants Operator Hello, and thank you for standing by for Tuniu's 2025 First Quarter Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.

TSPA closely mirrors the S&P 500 with minimal differentiation, making its higher 0.34% expense ratio hard to justify over cheaper passive alternatives. Despite active management, TSPA's returns and risk metrics are nearly identical to SPY, offering little added value or alpha for investors. The fund's short track record and lack of outperformance suggest waiting before considering it as a core holding in a portfolio.

JNUG is designed as a daily trading tool for leveraged exposure to junior gold miners, not as a long-term investment vehicle. The daily reset and use of derivatives cause performance decay over time, making JNUG unsuitable for buy-and-hold strategies. JNUG's holdings are highly liquid, minimizing redemption cascade risk, and it trades close to net asset value during market hours.

GE Vernova's Gas Power unit gains momentum from AI-fueled energy demand, landing major turbine deals in Q1 2025.

The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22 BALTIMORE , June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T.